Annual Operating Expenses
$233.71 M
+$53.49 M+29.68%
December 31, 2024
Summary
- As of March 12, 2025, PRCT annual total operating expenses is $233.71 million, with the most recent change of +$53.49 million (+29.68%) on December 31, 2024.
- During the last 3 years, PRCT annual operating expenses has risen by +$163.68 million (+233.74%).
- PRCT annual operating expenses is now at all-time high.
Performance
PRCT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$63.38 M
+$4.04 M+6.82%
December 31, 2024
Summary
- As of March 12, 2025, PRCT quarterly total operating expenses is $63.38 million, with the most recent change of +$4.04 million (+6.82%) on December 31, 2024.
- Over the past year, PRCT quarterly operating expenses has increased by +$4.04 million (+6.82%).
- PRCT quarterly operating expenses is now at all-time high.
Performance
PRCT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PRCT Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.7% | +6.8% |
| 3 y3 years | +233.7% | +6.8% |
| 5 y5 years | +460.9% | +6.8% |
PRCT Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +233.7% | at high | +196.9% |
| 5 y | 5-year | at high | +460.9% | at high | +479.0% |
| alltime | all time | at high | +460.9% | at high | +479.0% |
PROCEPT BioRobotics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $233.71 M(+29.7%) | $63.38 M(+6.8%) |
| Sep 2024 | - | $59.34 M(+1.8%) |
| Jun 2024 | - | $58.31 M(+10.7%) |
| Mar 2024 | - | $52.68 M(+3.7%) |
| Dec 2023 | $180.22 M(+53.0%) | $50.81 M(+14.2%) |
| Sep 2023 | - | $44.48 M(+1.0%) |
| Jun 2023 | - | $44.05 M(+7.8%) |
| Mar 2023 | - | $40.87 M(+14.4%) |
| Dec 2022 | $117.81 M | $35.72 M(+10.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $32.34 M(+22.7%) |
| Jun 2022 | - | $26.36 M(+12.7%) |
| Mar 2022 | - | $23.40 M(+9.6%) |
| Dec 2021 | $70.03 M(+50.4%) | $21.35 M(+25.3%) |
| Sep 2021 | - | $17.04 M(+1.6%) |
| Jun 2021 | - | $16.77 M(+12.8%) |
| Mar 2021 | - | $14.87 M(+8.7%) |
| Dec 2020 | $46.55 M(+11.7%) | $13.68 M(+24.9%) |
| Sep 2020 | - | $10.95 M |
| Dec 2019 | $41.66 M | - |
FAQ
- What is PROCEPT BioRobotics annual total operating expenses?
- What is the all time high annual operating expenses for PROCEPT BioRobotics?
- What is PROCEPT BioRobotics annual operating expenses year-on-year change?
- What is PROCEPT BioRobotics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for PROCEPT BioRobotics?
- What is PROCEPT BioRobotics quarterly operating expenses year-on-year change?
What is PROCEPT BioRobotics annual total operating expenses?
The current annual operating expenses of PRCT is $233.71 M
What is the all time high annual operating expenses for PROCEPT BioRobotics?
PROCEPT BioRobotics all-time high annual total operating expenses is $233.71 M
What is PROCEPT BioRobotics annual operating expenses year-on-year change?
Over the past year, PRCT annual total operating expenses has changed by +$53.49 M (+29.68%)
What is PROCEPT BioRobotics quarterly total operating expenses?
The current quarterly operating expenses of PRCT is $63.38 M
What is the all time high quarterly operating expenses for PROCEPT BioRobotics?
PROCEPT BioRobotics all-time high quarterly total operating expenses is $63.38 M
What is PROCEPT BioRobotics quarterly operating expenses year-on-year change?
Over the past year, PRCT quarterly total operating expenses has changed by +$4.04 M (+6.82%)